_its-exciting-in-the-investment-trust-sphere-at-the-moment-joe-bauernfreund-of-avi-preview-1.jpg "‘It’s exciting in the investment trust sphere at the moment’: Joe Bauernfreund of AVI from sphere investments Video Screenshot Preview 1")
Gallery_its-exciting-in-the-investment-trust-sphere-at-the-moment-joe-bauernfreund-of-avi-preview-3.jpg "‘It’s exciting in the investment trust sphere at the moment’: Joe Bauernfreund of AVI from sphere investments Video Screenshot Preview 3")
Gallery_its-exciting-in-the-investment-trust-sphere-at-the-moment-joe-bauernfreund-of-avi-preview-hqdefault.jpg "‘It’s exciting in the investment trust sphere at the moment’: Joe Bauernfreund of AVI from sphere investments Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 31 minutes 20 seconds
👁 View: 127 times
Play Audio:👁 View: 127 times
Description:
Investors' Chronicle
Investors' Chronicle
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
_sphere-europe-strategy.webp "SPHERE Investments")
_emerging-markets-short-video-sphere-investments.webp "Sphere Investments")
_stock-woes-leave-donald-trump39s-truth-social-backers-baffled.webp "Welcome to Fan Reviews News. It seems that small-time investors who eagerly purchased stock in Trump Media & Technology Group are now grappling with the realization that their Truth Social investment might not have been such a wise decision after all. There is growing concern among Trump's most fervent supporters that Truth Social might not reach the heights of success they had hoped for. As the value of shares continues to plummet, investors are expressing their faith in the success of this venture while simultaneously questioning whether they have made a terrible mistake. The fluctuating prices and disappointing returns have tested loyalty of Trump supporters. Only time will tell if Truth Social can overcome these challenges and deliver on its promises. We will keep you updated with the facts, on Fan Reviews News.")
_sphere-asset-and-property-management.webp "SPHERE Investments")
_top-30-funniest-snl-political-impressions.webp "\")
_the-experts-aren39t-telling-you-this-about-the-dollar.webp "George Gammon")
_resale-versus-new-homes-performances.webp "Alan Wee Property")
_latest-weight-loss-drug-faces-shortages.webp "Latest Weight-Loss Drug , Faces Shortages .<br/>The United States Food and Drug Administration <br/>(FDA) says that high demand has left the latest <br/>weight-loss drug, Zepbound, in short supply.<br/>'Newsweek' reports that the Eli Lilly product<br/>is expected to experience limited availability <br/>through Q2 of 2024 as surging demand has <br/>outpaced the manufacturer's expectations.<br/>We have experienced <br/>an unparalleled surge in <br/>demand for our type 2 <br/>diabetes and obesity medicines, Eli Lilly spokesperson, via 'Newsweek'.<br/>We recognize this situation may <br/>cause a disruption in peoples' <br/>treatment regimens and are <br/>working with purpose and <br/>urgency to help meet <br/>the surge in demand, Eli Lilly spokesperson, via 'Newsweek'.<br/>The FDA said that Novo Nordisk's weight-loss <br/>drug, Wegovy, is also experiencing a <br/>widespread supply shortage with no end <br/>in sight for the drug's limited availability.<br/>By the year 2030, 'Newsweek' reports <br/>that the weight-loss drug market is <br/>expected to grow to about $100 billion.<br/>We expect our investments <br/>in manufacturing and supply <br/>capacity to progressively increase <br/>production of our medicines <br/>throughout 2024 and beyond, Eli Lilly spokesperson, via 'Newsweek'.<br/>Over the past year, manufacturer Eli Lilly <br/>has already seen share prices rise over 102%.<br/>The company has announced plans <br/>to expand operations to meet increased <br/>demand for its incretin products which are <br/>used in the firm's diabetes treatments. .<br/>Incretin mimics gut hormones <br/>that regulate blood sugar <br/>while also suppressing appetite")
_sphere-europe-strategy.jpg)
_emerging-markets-short-video-sphere-investments.jpg)
_stock-woes-leave-donald-trump39s-truth-social-backers-baffled.jpg)
_sphere-asset-and-property-management.jpg)
_top-30-funniest-snl-political-impressions.jpg)
_the-experts-aren39t-telling-you-this-about-the-dollar.jpg)
_resale-versus-new-homes-performances.jpg)
_latest-weight-loss-drug-faces-shortages.jpg)
![[+]](/images/menu.gif){kind=small}